AIM ImmunoTech Stock (AMEX: AIM) stock price, news, charts, stock research, profile.
Open | $0.26 |
Close | - |
Volume / Avg. | 303.72K / 262.20K |
Day Range | $0.23 - $0.27 |
52 Wk Range | 0.21 - 0.62 |
Market Cap | $15.14M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 31 |
Short Interest | 0.93% |
Days to Cover | 1.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.
Other companies in AIM ImmunoTech’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
AIM ImmunoTech has a consensus price target of $5.00.
The stock price for AIM ImmunoTech (AMEX: AIM) is $0.265 last updated September 23, 2024 at 12:31 PM EDT.
There are no upcoming dividends for AIM ImmunoTech.
AIM ImmunoTech’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for AIM ImmunoTech.
AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.